ODTX (Odyssey Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Odyssey Therapeutics, Inc. Common Stock (ODTX) is a publicly traded the market company. As of May 21, 2026, ODTX trades at $16.98 with a market cap of $820.36M and a P/E ratio of 0.00. ODTX moved +0.35% today. Year to date, ODTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $15.35 to $20.30. Rallies surfaces ODTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns ODTX stock?
Rallies tracks hedge fund and 13F ownership for ODTX, including fund holders, share counts, and position changes when data is available.
TPG GP A, LLC bought 1.39M (~$25.00M) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC sold 1.06K (~$19.17K) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC bought 222.22K (~$4.00M) on May 11, 2026.
ODTX Analyst Consensus
ODTX analyst coverage data. Average price target: $0.00.
Common questions about ODTX
Who owns ODTX stock?
Rallies tracks hedge fund and 13F ownership for ODTX, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for ODTX?
Yes. Rallies tracks hedge fund and 13F ownership data for ODTX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ODTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ODTX. It does not provide personalized investment advice.